×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| SHREE PACETRONIX LTD. | NA | NA | NA | NA | 66.4 | 64.5 |
| Concord Drugs Limited | NA | NA | NA | NA | 66 | 153.0 |
| Aspira Pathlab & Diagnostics L | NA | NA | NA | NA | 64.8 | 25.3 |
Shree Pacetronix Ltd, with Security Code 527005, is a leading player in the Medical Equipment & Supplies industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.2 | 7.5 | 5.9 | 5.2 | 4.3 | 6.7 | 4.9 | 4.0 | 3.6 | 4.3 |
| Expenses | 4.1 | 4.5 | 4.5 | 4.1 | 3.4 | 4.4 | 4.1 | 3.7 | 3.5 | 3.3 |
| Operating Profit | 1.1 | 3.0 | 1.4 | 1.2 | 0.9 | 2.3 | 0.8 | 0.4 | 0.1 | 1.0 |
| OPM % | 21.37% | 39.89% | 23.44% | 22.09% | 19.79% | 34.42% | 15.62% | 9.27% | 3.17% | 23.57% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 |
| Profit before tax | 0.9 | 2.8 | 1.2 | 0.9 | 0.6 | 2.0 | 0.5 | 0.1 | -0.2 | 0.7 |
| Tax % | -30.5% | -29.4% | -26.9% | -22.8% | -28.9% | -29.1% | -26.2% | -43.1% | -30.7% | -15.4% |
| Net Profit | 0.6 | 2.0 | 0.9 | 0.7 | 0.4 | 1.4 | 0.4 | 0.0 | -0.1 | 0.5 |
| EPS in Rs | 1.72 | 5.5 | 2.41 | 1.85 | 1.11 | 3.96 | 1.03 | 0.08 | -0.32 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.2 | 7.5 | 5.9 | 5.2 | 4.3 | 6.7 | 4.9 | 4.0 | 3.6 | 4.3 |
| Expenses | 4.1 | 4.5 | 4.5 | 4.1 | 3.4 | 4.2 | 4.1 | 3.6 | 3.5 | 3.2 |
| Operating Profit | 1.1 | 3.0 | 1.4 | 1.2 | 0.8 | 2.4 | 0.8 | 0.4 | 0.1 | 1.0 |
| OPM % | 21.31% | 39.48% | 23.39% | 22.03% | 19.72% | 36.5% | 16.15% | 9.97% | 3.97% | 24.3% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 |
| Profit before tax | 0.9 | 2.8 | 1.2 | 0.9 | 0.6 | 2.0 | 0.5 | 0.1 | -0.2 | 0.7 |
| Tax % | -30.9% | -29.4% | -26.9% | -22.9% | -29% | -29.1% | -26.1% | -37% | -31.9% | -15.5% |
| Net Profit | 0.6 | 2.0 | 0.9 | 0.7 | 0.4 | 1.4 | 0.4 | 0.0 | -0.1 | 0.5 |
| EPS in Rs | 1.71 | 5.44 | 2.4 | 1.85 | 1.1 | 3.98 | 1.03 | 0.09 | -0.31 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 25% |
| 3 Years: | 43% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 124% |
| 3 Years: | 165% |
| TTM: | -56% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 47% |
| 3 Years: | 61% |
| 1 Year: | -63% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 25% |
| 3 Years: | 43% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 117% |
| 3 Years: | 307% |
| TTM: | -56% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 47% |
| 3 Years: | 61% |
| 1 Year: | -63% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|